686 related articles for article (PubMed ID: 1409431)
41. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study.
Wolf P; Quehenberger F; Müllegger R; Stranz B; Kerl H
Melanoma Res; 1998 Aug; 8(4):370-8. PubMed ID: 9764814
[TBL] [Abstract][Full Text] [Related]
42. Incidence of cutaneous malignant melanoma in Israel, 1960-1989.
Iscovich J; Andreev H; Steinitz R
Public Health Rev; 1995; 23(1):1-23. PubMed ID: 7761605
[TBL] [Abstract][Full Text] [Related]
43. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
44. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
[TBL] [Abstract][Full Text] [Related]
45. Risk of malignant transformation of congenital melanocytic nevi: a retrospective nationwide study from The Netherlands.
Zaal LH; Mooi WJ; Klip H; van der Horst CM
Plast Reconstr Surg; 2005 Dec; 116(7):1902-9. PubMed ID: 16327602
[TBL] [Abstract][Full Text] [Related]
46. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
47. High constant incidence rates of second cutaneous melanomas.
Levi F; Randimbison L; Te VC; La Vecchia C
Int J Cancer; 2005 Dec; 117(5):877-9. PubMed ID: 15957164
[TBL] [Abstract][Full Text] [Related]
48. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98.
Nieto A; Ruiz-Ramos M; Abdel-Kader L; Conde M; Camacho F
Br J Dermatol; 2003 Jan; 148(1):110-6. PubMed ID: 12534603
[TBL] [Abstract][Full Text] [Related]
49. [Malignant melanoma in German-speaking countries in the 80's. Initial results of the central registry for malignant melanoma of the Germany Society of Dermatology in cooperation with the federal health office].
Garbe C; Bertz J; Orfanos CE
Hautarzt; 1987 Nov; 38(11):639-44. PubMed ID: 3501419
[TBL] [Abstract][Full Text] [Related]
50. Malignant melanoma in southern Germany: different predictive value of risk factors for melanoma subtypes.
Weiss J; Bertz J; Jung EG
Dermatologica; 1991; 183(2):109-13. PubMed ID: 1743370
[TBL] [Abstract][Full Text] [Related]
51. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
[TBL] [Abstract][Full Text] [Related]
52. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study.
Stierner U; Augustsson A; Rosdahl I; Suurküla M
Melanoma Res; 1992; 1(5-6):367-75. PubMed ID: 1422192
[TBL] [Abstract][Full Text] [Related]
53. Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register.
Lyth J; Mikiver R; Nielsen K; Isaksson K; Ingvar C
Eur J Cancer; 2016 May; 59():171-178. PubMed ID: 27046697
[TBL] [Abstract][Full Text] [Related]
54. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Büttner P; Weiss J; Soyer HP; Stocker U; Krüger S; Roser M; Weckbecker J; Panizzon R; Bahmer F
J Invest Dermatol; 1994 May; 102(5):695-9. PubMed ID: 8176250
[TBL] [Abstract][Full Text] [Related]
55. Outdoor work and skin cancer incidence: a registry-based study in Bavaria.
Radespiel-Tröger M; Meyer M; Pfahlberg A; Lausen B; Uter W; Gefeller O
Int Arch Occup Environ Health; 2009 Feb; 82(3):357-63. PubMed ID: 18649084
[TBL] [Abstract][Full Text] [Related]
56. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Fraser MC; Clark WH; Tucker MA
J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
[TBL] [Abstract][Full Text] [Related]
58. Melanoma in Western Australia in 1980-81: incidence and characteristics of histological types.
English DR; Heenan PJ; Holman CD; Armstrong BK; Blackwell JB; Kelsall GR; Matz LR; Singh A; Ten Seldam RE
Pathology; 1987 Oct; 19(4):383-92. PubMed ID: 3444664
[TBL] [Abstract][Full Text] [Related]
59. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.
Whiteman DC; Watt P; Purdie DM; Hughes MC; Hayward NK; Green AC
J Natl Cancer Inst; 2003 Jun; 95(11):806-12. PubMed ID: 12783935
[TBL] [Abstract][Full Text] [Related]
60. Primary cutaneous malignant melanoma: experience of the British Columbia Cancer Agency from 1972 to 1981.
Carmichael VE; Wilson KS
Can J Surg; 1992 Dec; 35(6):589-97. PubMed ID: 1458384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
